Advocate 'gutted' as PHARMAC reviews blanket funding of child cancer medicines

2 November 2022 - Rule 8.1b of the Pharmaceutical Schedule allows all child cancer medicines to be funded by PHARMAC. ...

Read more →

PHARMAC promises equity boost in first official response to independent review

6 September 2022 - PHARMAC will supercharge its commitment to Māori and diverse communities, which could see different medicines funded, ...

Read more →

Accelerating pooled licensing of medicines to enhance global production and equitable access

8 July 2022 - From October to November, 2021, the pharmaceutical firms Merck and Pfizer licensed their new COVID-19 oral antiviral ...

Read more →

ICER launches initiative to evaluate and advance health technology assessment methods that support health equity

11 July 2022 - Funding from Commonwealth Fund supports a broad based initiative exploring potential changes in all health technology assessment ...

Read more →

Patient reported outcome assessment must be inclusive and equitable

5 May 2022 - Patient reported outcomes are increasingly collected in clinical trials and in routine clinical practice, but strategies ...

Read more →

Vaccine approval before Phase 3 trial results: a consequence of vaccine access inequity

2 March 2022 - The final Phase 3 clinical data for CanSino Biologics' adenovirus type 5 vector vaccine show that Ad5-nCoV ...

Read more →

Equity in cancer drug access in the UK

1 February 2022 - In draft guidance published on 5 January 2022, NICE announced their decision not to recommend the use ...

Read more →

Funding Keytruda for melanoma but not for lung cancer is racist, health advocates say

8 December 2021 - PHARMAC has been accused of institutional racism and breaching the Treaty of Waitangi for funding drugs ...

Read more →

Inclusion in health technology assessments: the first step toward equity

10 November 2021 - Many researchers working on health technology assessments are keen to address disparities in health care.  ...

Read more →

On new recommendation for treatment of COVID-19 patients: WHO calls for equitable access to casirivimab and imdevimab for COVID-19

24 September 2021 - The World Health Organization welcomes the addition of another therapeutic to the world’s arsenal against COVID-19, ...

Read more →

Booster shots ‘make a mockery of vaccine equity,’ the WHO’s Africa director says

19 August 2021 - The Africa director at the World Health Organization, Dr. Matshidiso Moeti, criticized the decisions by some ...

Read more →

ICER to test principle of fair access to fairly priced pharmaceuticals

2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...

Read more →

Modifying NICE’s approach to equity weighting

7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...

Read more →

Vaccine distribution—equity left behind?

29 January 2021 - Over the past 2 weeks numerous US states have announced a major shift in coronavirus disease ...

Read more →

Big Pharma’s new CEOs must step up to erase inequities in drug access

16 December 2020 - I have been asked many times: Does the vision of the CEO have the power to ...

Read more →